What to do about poor clinical performance in clinical trials

摘要

Guidelines on research governance from the Department of Health emphasise the importance of patient safety in trials We suggest that healthcare organisations should make the trial management team responsible for monitoring safety through statistical analysis Taking action on suboptimal results, however, remains the institution's responsibility The rules for monitoring and responding to suboptimal performance should be made clear to everyone in advance.